Mannkind (MNKD) Assets Average (2011 - 2026)
Mannkind (MNKD) posted quarterly Assets Average of $768.3 million for Q1 2026, up 91.12% year-over-year from $402.0 million in Q1 2025, and up 19.41% quarter-over-quarter from $643.4 million in Q4 2025.
Mannkind (MNKD) Assets Average (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Assets Average for 16 consecutive years, with $768.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 91.12% year-over-year to $768.3 million; the TTM figure through Mar 2026 stood at $768.3 million (up 91.12% YoY), while the FY2025 annual figure was $593.0 million, up 36.48% from the prior year.
- Assets Average improved to $768.3 million in Q1 2026 per MNKD's latest filing, from $643.4 million in the prior quarter.
- Across five years, Assets Average topped out at $768.3 million in Q1 2026 and bottomed at $289.8 million in Q3 2022.
- Historically, Assets Average has averaged $412.6 million across 5 years, with a median of $402.0 million in 2025.
- Annual changes were most pronounced in 2025 — Assets Average fell 15.91% — and 2026, when it jumped 91.12%.
- Mannkind's Assets Average stood at $294.6 million in 2022, then jumped by 35.04% to $397.8 million in 2023, then climbed by 7.86% to $429.0 million in 2024, then soared by 49.97% to $643.4 million in 2025, then increased by 19.41% to $768.3 million in 2026.
- Business Quant data shows MNKD's Assets Average at $768.3 million in Q1 2026, $643.4 million in Q4 2025, and $453.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 738.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 738.35 Mn |
| Mar 31, 2026 | 768.29 Mn |
| Dec 31, 2025 | 643.41 Mn |
| Sep 30, 2025 | 453.17 Mn |
| Jun 30, 2025 | 410.92 Mn |
| Mar 31, 2025 | 401.99 Mn |
| Dec 31, 2024 | 429.02 Mn |
| Sep 30, 2024 | 454.02 Mn |
| Jun 30, 2024 | 462.36 Mn |
| Mar 31, 2024 | 478.04 Mn |
| Dec 31, 2023 | 397.76 Mn |
| Sep 30, 2023 | 316.88 Mn |
| Jun 30, 2023 | 305.78 Mn |
| Mar 31, 2023 | 296.71 Mn |
| Dec 31, 2022 | 294.56 Mn |
| Sep 30, 2022 | 289.82 Mn |
| Jun 30, 2022 | 297.06 Mn |
| Mar 31, 2022 | 314.74 Mn |
| Dec 31, 2021 | 279.68 Mn |
| Sep 30, 2021 | 245.50 Mn |